Hemostatic Agent Development

Award Information
Agency: Department of Defense
Branch: Navy
Contract: N00014-10-M-0481
Agency Tracking Number: N101-085-1139
Amount: $70,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2010
Solicitation Year: 2010
Solicitation Topic Code: N101-085
Solicitation Number: 2010.1
Small Business Information
55 W. L. Runnels Industrial Dr., Hattiesburg, MS, 39401
DUNS: 147162866
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Joseph Lichtenhan
 (601) 544-3466
Business Contact
 Carl Hagstrom
Title: Chief Operating Officer
Phone: (601) 544-3466
Email: Chagstrom@hybridplastics.com
Research Institution
The proposed effort comprises a treatment combination using the platelet binding hemostatic capability of Nanoscopic Chemicals known as POSS trisilanols in combination with hyaluronic acid media, and antibiotic drugs in liquid and foam form. Mechanistically, liquid POSS trisilanols are injectable and serve to bind platelets to immediately stop bleeding. Subsequently the bound plateles release a multitude of natural growth factors while in the presence of a supplement of Hyaluronic acid (HA). Growth factors in combination with high amounts of HA are known to aid tissue repair and preservation.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government